These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32251197)

  • 1. Apparent treatment-resistant hypertension: characteristics and prevalence in a real-world environment of an integrated health system.
    An J; Sim JJ; Calhoun DA; Liu R; Wei R; Zhou H; Luong T; Reynolds K
    J Hypertens; 2020 Aug; 38(8):1603-1611. PubMed ID: 32251197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.
    Muntner P; Carey RM; Gidding S; Jones DW; Taler SJ; Wright JT; Whelton PK
    Circulation; 2018 Jan; 137(2):109-118. PubMed ID: 29133599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Apparent Treatment-Resistant Hypertension in Chronic Kidney Disease in Two Large US Health Care Systems.
    An J; Kurella Tamura M; Odden MC; Ni L; Thomas IC; Montez-Rath ME; Sim JJ
    Clin J Am Soc Nephrol; 2022 Oct; 17(10):1457-1466. PubMed ID: 36400564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential U.S. Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.
    Muntner P; Carey RM; Gidding S; Jones DW; Taler SJ; Wright JT; Whelton PK
    J Am Coll Cardiol; 2018 Jan; 71(2):109-118. PubMed ID: 29146532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Apparent Treatment-Resistant Hypertension in the United States.
    Carey RM; Sakhuja S; Calhoun DA; Whelton PK; Muntner P
    Hypertension; 2019 Feb; 73(2):424-431. PubMed ID: 30580690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the 2017 ACC/AHA guideline on the prevalence of elevated blood pressure and hypertension: a cross-sectional analysis of 10 799 individuals.
    Alyabsi M; Gaid R; Alqunaibet A; Alaskar A; Mahmud A; Alghamdi J
    BMJ Open; 2020 Dec; 10(12):e041973. PubMed ID: 33384395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Impact of 2017 American College of Cardiology/American Heart Association Hypertension Guideline on Contemporary Practice: A Cross-Sectional Analysis From NCDR PINNACLE Registry.
    Hussain A; Virani SS; Zheng L; Gluckman TJ; Borden WB; Masoudi FA; Maddox TM
    J Am Heart Assoc; 2022 Jun; 11(11):e024107. PubMed ID: 35656989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Underutilization of Treatment for Black Adults With Apparent Treatment-Resistant Hypertension: JHS and the REGARDS Study.
    Langford AT; Akinyelure OP; Moore TL; Howard G; Min YI; Hillegass WB; Bress AP; Tajeu GS; Butler M; Jaeger BC; Yano Y; Shimbo D; Ogedegbe G; Calhoun D; Booth JN; Muntner P
    Hypertension; 2020 Nov; 76(5):1600-1607. PubMed ID: 32924633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of ambulatory blood pressure phenotypes using the 2017 American College of Cardiology/American Heart Association blood pressure guideline thresholds: data from the Coronary Artery Risk Development in Young Adults study.
    Poudel B; Booth JN; Sakhuja S; Moran AE; Schwartz JE; Lloyd-Jones DM; Lewis CE; Shikany JM; Shimbo D; Muntner P
    J Hypertens; 2019 Jul; 37(7):1401-1410. PubMed ID: 31145711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the European and American guidelines on hypertension prevalence, treatment, and cardiometabolic goals.
    Gijón-Conde T; Sánchez-Martínez M; Graciani A; Cruz JJ; López-García E; Ortolá R; Rodríguez-Artalejo F; Banegas JR
    J Hypertens; 2019 Jul; 37(7):1393-1400. PubMed ID: 31145710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the association of masked hypertension defined by the 2017 ACC/AHA BP guideline versus the JNC7 guideline with left ventricular hypertrophy.
    Poudel B; Viera AJ; Shimbo D; Schwartz JE; Shikany JM; Sakhuja S; Lloyd-Jones DM; Muntner P; Yano Y
    J Hypertens; 2022 Aug; 40(8):1597-1606. PubMed ID: 35792106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agreement between 2017 ACC/AHA Hypertension Clinical Practice Guidelines and Seventh Report of the Joint National Committee Guidelines to Estimate Prevalence of Postmenopausal Hypertension in a Rural Area of Bangladesh: A Cross Sectional Study.
    Barua L; Faruque M; Banik PC; Ali L
    Medicina (Kaunas); 2019 Jun; 55(7):. PubMed ID: 31248050
    [No Abstract]   [Full Text] [Related]  

  • 13. Estimated Change in Prevalence of Hypertension in Nepal Following Application of the 2017 ACC/AHA Guideline.
    Kibria GMA; Swasey K; Kc A; Mirbolouk M; Sakib MN; Sharmeen A; Chadni MJ; Stafford KA
    JAMA Netw Open; 2018 Jul; 1(3):e180606. PubMed ID: 30646022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of hypertension among Bangladeshi adults using the 2017 ACC/AHA Hypertension Clinical Practice Guidelines and Joint National Committee 7 Guidelines.
    Islam JY; Zaman MM; Haq SA; Ahmed S; Al-Quadir Z
    J Hum Hypertens; 2018 Oct; 32(10):668-680. PubMed ID: 30026561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Status of Hypertension in Tehran: Potential impact of the ACC/AHA 2017 and JNC7 Guidelines, 2012-2015.
    Asgari S; Khaloo P; Khalili D; Azizi F; Hadaegh F
    Sci Rep; 2019 Apr; 9(1):6382. PubMed ID: 31011156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Hypertension, Treatment, and Blood Pressure Targets in Canada Associated With the 2017 American College of Cardiology and American Heart Association Blood Pressure Guidelines.
    Garies S; Hao S; McBrien K; Williamson T; Peng M; Khan NA; Padwal RS; Quan H; Leung AA;
    JAMA Netw Open; 2019 Mar; 2(3):e190406. PubMed ID: 30848811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood Pressure Control and Cardiovascular Outcomes: Real-world Implications of the 2017 ACC/AHA Hypertension Guideline.
    Lee JH; Kim SH; Kang SH; Cho JH; Cho Y; Oh IY; Yoon CH; Lee HY; Youn TJ; Chae IH; Kim CH
    Sci Rep; 2018 Sep; 8(1):13155. PubMed ID: 30177714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential epidemiological impact of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on the Chinese population: a cross-sectional study in rural areas of Liaoning Province.
    Dong Y; Sun Z; Li Z; Guo X; Sun G; Xie Y; Zheng J; Dai Y; Wang Y; Guo R; Zheng L; Sun Y
    BMJ Open; 2020 Sep; 10(9):e035900. PubMed ID: 32963064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care.
    de Beus E; van der Sande NGC; Bots ML; Spiering W; Voskuil M; Visseren FLJ; Blankestijn PJ
    BMJ Open; 2017 Sep; 7(9):e016692. PubMed ID: 28882918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M;
    Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.